Non-equilibrium plasma prevention of Schistosoma japonicum transmission

Abstract

Schistosoma japonicum is a widespread human and animal parasite that causes intestinal and hepatosplenic schistosomiasis linked to colon, liver and bladder cancers, and anemia. Estimated 230 million people are currently infected with Schistosoma spp, with 779 million people at risk of contracting the parasite. Infection occurs when a host comes into contact with cercariae, a planktonic larval stage of the parasite, and can be prevented by inactivating the larvae, commonly by chemical treatment. We investigated the use of physical non-equilibrium plasma generated at atmospheric pressure using custom-made dielectric barrier discharge reactor to kill S. japonicum cercariae. Survival rate decreased with treatment time and applied power. Plasmas generated in O2 and air gas discharges were more effective in killing S. japonicum cercariae than that generated in He, which is directly related to the mechanism by which cercariae are inactivated. Reactive oxygen species, such as O atoms, abundant in O2 plasma and NO in air plasma play a major role in killing of S. japonicum cercariae via oxidation mechanisms. Similar level of efficacy is also shown for a gliding arc discharge plasma jet generated in ambient air, a system that may be more appropriate for scale-up and integration into existing water treatment processes.

Disinfection and Sterilization Using Plasma Technology: Fundamentals and Future Perspectives for Biological Applications

“…Plasma is also effective against other microorganisms besides the ones mentioned above. For example, plasma inactivation of the yeast-like algae Prototheca zopfii [69] and water-borne helminth Schistosoma japonicum [70], Acanthamoeba species (spp. ), and other ocular pathogens, as well as water-borne protozoan enteroparasite Cryptosporidium parvum when combined with pulsed UV [71] was confirmed.…”

Metallic Biomaterials: Current Challenges and Opportunities

“…Plasma-enabled biomedical technologies have emerged as a promising approach for non-chemical, low-temperature decontamination in the biomedical, food manufacturing and food service industries, and synergistic and personalised plasma-enabled therapeutics for tissue regeneration and oncotherapy [ 133 , 134 , 135 , 136 ]. There is a rapidly increasing body of literature where low-temperature plasmas have been used to rapidly disinfect living and abiotic targets, drive cell differentiation and migration, and promote tissue regeneration and wound healing, and, in cancer therapy, to reduce or fully eliminate tumours, halt metastasis, enhance local and systemic immune function and selectively induce apoptosis in cancer cells.…”

Improved fermentation efficiency of S. cerevisiae by changing glycolytic metabolic pathways with plasma agitation

“…cerevisiae fermentation processes. Non-thermal plasmas are partially ionized gases which are generated by supplying energy to gaseous medium leading to dissociation of molecular bonds and ionization reactions 40 , 41 . Hence, plasma consists of positively and negatively charged ions, electrons as well as neutral atoms and molecules (e.g.…”